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Abstract
Over the past years, the field of synthetic biology has gained a significant array of tools
and parts, making way for increasingly complex bio-molecular circuits to be constructed.
The development of biocircuits can be facilitated by assembling parts in a less complex,
cell-free, environment which contains only the machinery for gene transcription (TX)
and translation (TL), which have been extracted from bacteria. In this project, a part
library  was  collected  and  used  to  assemble  DNA  constructs  for  a  newly  designed
biocircuit. An in vitro TX-TL extract was used to test the circuit modules using linear
DNA, and in parallel with predictive modeling of the biomolecular reactions, the overall
circuit  design  was  evaluated.  The  results  have  given  valuable  insight  into  the
performance of the circuit modules in a much shorter time than conventional  in vivo
cloning and testing would have achieved.
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1. Introduction
The discovery of the DNA helix structure in 1953 marked the starting point of the 
endeavor to break down and understand how living things store genetic information and
how it is used to control their biology on both a micro and macro scale [1], [2]. With 
increased understanding of the complex control network which governs how and when 
genetic information is used, the ability to genetically alter various life-forms, ranging 
from viruses to mammals, emerged. This has paved way for the research field of 
synthetic biology where novel biological systems, such as genetically modified organisms,
are created by manipulating the biomolecular network that controls all life [3]. In this 
thesis, the latest tools of synthetic biology have been used to design and prototype a 
circuit of genetic regulator modules. This biocircuit, once carefully prototyped and 
tuned, could be implemented in bacteria to create a genetically modified bacterial strain 
which respond to inputs according to the circuit logic.
This chapter covers the fundamental ideas behind the research of this thesis. To aid the 
reader with field specific terminology, a glossary section (Appendix 7.1) is provided for 
terms marked in italics.
1.1. Background to synthetic molecular biology
Synthetic biology has previously been defined as the endeavor to design and construct 
new biological parts, devices and systems, and even re-designing the existing, natural 
biological systems, for useful purposes [4], [5]. This can be achieved on different scales, 
ranging from animal and plant engineering, to the individual cell and bacteria level, and 
all the way down to the biomolecular level involving protein and nucleic acid 
manipulations. The initial phase of biomolecular research was mainly concerned with 
understanding and describing the underlying mechanisms and made great progress in 
developing the tools necessary to study these systems. New biomolecular tools, such as 
the Nobel Prize winning development of restriction digest enzymes [6], paved the way 
for engineers and scientists to build new biological networks, resulting in both increased 
understanding of existing systems and a growing library of parts and modules which 
have been engineered towards perfection.
Although synthetic biology has largely focused on creating genetically modified 
organisms (GMOs) for various industrial, agricultural and scientific purposes, some work
is also done on in vitro use of molecular biology systems with the aim of empowering 
technology with the flexibility and specificity of biology while by-passing the limitations 
of living cells, such as crosstalk with competing cell processes, tuning of growth 
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conditions and the spontaneous generation of mutations [3], [7]. 
1.2. Genetic biocircuits
Developing biological circuits is a key process when engineering advanced genetically-
modified organisms (GMOs). With an increasing ability to design and assemble complex 
genetic circuits, fields such as bio-medicine, environmental monitoring and fuel 
production, among others, could potentially be made cleaner and more efficient with the
tools of synthetic biology. The knowledge gained from implementing biochemical circuits
in living organisms can also be used to provide further understanding about the complex
network of gene expressions that controls cell functions [8].
In recent years, biocircuits with increasing complexity have been developed, and the 
building blocks that have been created can now be used for new, even more complex, 
circuits. The synthetic biology community has over the years collected and characterized
a vast number up genetic parts, such as promoters, hybrid promoters, transcription 
factors (such as repressors and activators), fluorescent mRNAs and proteins, interfering 
mRNAs, enzymes and kinases to allow for circuit development. This library of parts can 
be used to, in theory, build any circuit logic function wanted. However, the performance 
of each part in terms of efficiency, cell toxicity and orthogonality to other parts, among 
other features, needs to be evaluated. Therefore there is a bias towards using well 
documented parts rather than introducing new ones that have not been thoroughly 
characterized [3].
By using this array of characterized parts, many circuits have been designed and 
realized, both in vivo and in cell-free breadboards in vitro. Logic gates, such as AND-, 
NOT- and NAND-gates, have previously been created within living cells [9]. These logic 
gates, when implemented in bacteria, can be used to steer bacterial behavior depending 
on external input such as hormones, inducer molecules, temperature and even light 
stimuli [10], [11]. This can be achieved by using transcription factors which change 
properties when exposed to certain molecules or conditions, an example of which is the 
repressor protein LacI which forms a complex with the lactose derivative Isopropyl-b-D-
thiogalactopyranoside (IPTG) and, in doing so, looses its ability to repress specific 
promoters when the inducer is present in solution [12]. The growing library of well 
characterized parts and modules gives scientists new tools to further engineer bacteria 
for improved performance in various applications [3].
Biocircuit diagrams are used to provide an overview of the network of biochemical 
reactions that create the circuit logic. Figure 1 shows an example of an activator-
repressor cascade diagram, with the relevant reactions included. Circuit digrams, such as
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this, will be used extensively throughout this thesis to illustrate the prototyped circuits  
and their expected output.
To simplify these diagrams, the transcriptional and translational details are often 
excluded and only the activating and repressing arrows are shown. Circuit truth tables 
show how the output is expected to change depending on the input concentrations. For 
any gives species, '0' denotes low or zero concentration and '1' denotes high or 
saturating concentration.
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Figure 1: An example of a biocircuit diagram; an activator-repressor two-step cascade. The 
output from the reporter construct is controlled by the concentration of inducers IPTG and 
3OC6 in accordance with the circuit truth table. For more details about DNA constructs, see 
section '1.5. Cloning and DNA assembly'.
Combining circuit modules, like logic gates, has allowed for complex multi-input circuits 
such as the Four-input AND-gate (by Moon et al, shown in Figure 2) to be created. This
circuit uses inducible transcription factors to control the AND-gates modules consisting 
of hetero-dimer transcription factors [13]. This circuit is of interest, not only because of 
its impressive number of integrated parts, but also because of the three new AND-gate 
modules which where used to build it. In section 1.8.2, these AND-gate modules are 
further explained and evaluated as candidate building blocks for circuit designs.
1.2.1. Logic gates
Logic gates are devices that perform logic operations with one or more inputs resulting 
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Figure 2: The Four-input AND-gate created by Moon et al. [13], reprinted with permission. Four
signal molecules; Ara, IPTG, 3OC6 and aTc are used to activate (or release the repression from)
four different promoters (pBAD, pTac, pLux and pTet respectively). This results in the 
production of transcription factors and chaperones which together activate the pipaH* and 
pexsC promoters. When the first two AND-gate modules are activated, the two proteins needed 
to to activate pSicA are produced which results in a detectable RFP production. 
in a logic output. In modern day computers, logic gates are the basis on which memory 
and computation is built, and the electronic circuits in a microprocessor can contain 
more than 100 million gates. However, the concept of logic gates are not limited to 
electronic circuits; logic gates have been created using mechanical, optical, fluidic and 
even biomolecular systems. Figure 3 shows a set of the most fundamental logic gates 
which take one or two inputs and turns those into an output. In the circuit truth tables,
provided to the right of each gate, the logic in displayed. When designing biocircuits, the
concept of logic gates is often applied to describe the idealized circuit response to certain
inputs. For instance, in this project biomolecular logic AND-gates have been tested and 
used to build a larger gate with a NOR-gate logic.  
1.2.2. Measurable outputs
When designing biocircuits it is important to consider how the system can be observed. 
If the circuit output cannot be easily measured and quantified, both trouble-shooting 
and benchmarking will become difficult. Hence, the output of a circuit usually include a 
biomolecular reporter. Commonly used reporters are for instance fluorescent proteins, 
fluorescent mRNA aptamers and luminescent proteins. 
Fluorescent proteins of different colors have been engineered from the wild-type genes, 
such as green fluorescent protein (GFP) which is found in a certain species of jellyfish 
(Aequorea victoria). The GFP protein, and its derivatives, forms a cylinder shape with  
a chromophore center which can absorb light in the violet spectra and emit in the green 
spectra. The process of forming the structure necessary to fluoresce is called maturation 
and normally take between 40 and 120 min (with great variability depending on 
conditions). Many variants of GFP have been developed to enhance its performance and
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Figure 3: Logic gates with their symbols and corresponding truth tables. These logic gates have
one or two inputs (A&B) and one output (C). In the truth tables, 1 denotes a high signal and 0
denotes a low/zero signal.
usability, such as the super-folder variant 'sfGFP' which matures much faster than the 
wild-type GFP in a range of conditions. Multiple fluorescence colors of GFP mutants 
have also been created, with emission peaks ranging from blue to yellow [14].
Similarly to the fluorescent proteins there are reporters consisting of RNA aptamers 
(short single-stranded RNA pieces) and specific dyes which come together to for a 
fluroescent complex. These reporters make it possible to measure transcriptional events 
rather than the output of the whole transcription-translation process as with fluorescent 
proteins. This results in a faster generation of output compared to GFP and its mutants
[15]. 
Luminescent proteins, such as 'Luciferase', generate light through an oxidative 
enzymatic reaction with a substrate molecule, Luciferin. These type of proteins are the 
source of bioluminescense for many organism, such as fireflies, and certain species of 
beetles, worms, mushrooms and photo-bacteria. The Luciferase enzyme catalyses the 
oxidation of Luciferin to form a product in an excited state which then emits light to 
relax down to its ground state. The reaction consumes both ATP and oxygen [16].
For detection of gene expression in bacteria, a great variety of reporters excist, all with 
distinct advantages and disadvantages. Fluorescent proteins do not require any dye or 
ATP for measurement, but the maturation time introduces an unwanted delay in output
signal. RNA aptamer reporters give a fast response time, but the quick degradation of 
mRNA in cells can be a limiting factor. Luminescent proteins can give a strong output 
signal for low-light measuring. However, since the luminescence process consumes ATP, 
these reporters may be less suitable in situations where resources are scarce [16].
In this project, the fluorescent proteins deGFP and sfGFP have been used exclusively. 
These are lab standard reporters in the Murray Biocircuits lab where research was 
conducted, providing a highly useful basis for comparison with previous experiments as 
well as plate-reader calibration data which allowed for the quantification of output in 
nM (nanomolar units) rather than RFUs (relative fluorescent units).
1.3. Cell-free transcription-translation (TX-TL) systems
The development of biocircuits can be facilitated by assembling parts in a less complex, 
cell-free, environment which contains only the machinery for gene transcription (TX) 
and translation (TL) which have been extracted from bacteria. Such a 'breadboard' for 
synthetic biocircuits has been developed and successfully used for prototyping 
increasingly complex circuits [7], [8], [17]. This cell-free TX-TL system (here on referred 
to as just 'TX-TL') has the advantage that individual circuit parts can be tested 
without the adverse effects of 'cross-talk' with other cell functions, and it allows for 
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rapid parts testing and part mining. In addition, cell parameters (such as ATP 
concentration, ion balance etc) can easily be controlled [7]. 
One challenge when prototyping biocircuits in a cell-free system is to find out how the 
test tube results correlate to circuit behavior within cells. For TX-TL to become a 
widely used circuit design tool this in vitro to in vivo mapping needs to be thoroughly 
explored and ultimately quantified. This work aims to contribute to an increased 
understanding of this mapping by re-characterizing modules in TX-TL which have 
previously been characterized in vivo. 
1.4. Synthetic biology: research and applications
Synthetic biology is the focus subject for many prominent research groups world-wide. 
In bio-computation in mamalian cells, the 'Department of Biosystems Science and 
Engineering' at ETH Zurich is in the fore-front. Their work on creating modular systems
for high performance bio-computer, with applications in, for example, creating circuits 
capable of detecting cancer mutations within cells (cell differentiation detection), 
allowing gene therapy to heal organisms from the disease by selectively inducing self-
destruction mechanisms in dangerously mutated cells. The group has published several 
papers on bio-computation and new tool-sets for modular circuit development [18]–[20]. 
Other prominent biocircuit labs are the 'Voigt lab' at MIT and UCSF Biochemistry 
department, which jointly have developed the previously mentioned Four-input AND-
gate [13]. 
At University of Minnesota, the Noireaux lab has worked with extending the use of cell-
free extracts to explore synthetic biology systems from an in vitro perspective. With the 
use of TX-TL extracts, they have acheived self-assembly of artificial cytoskeletons in 
liposomes [21] and synthesized complete bacteriophages viruses from their genome [22]. 
Thus, they have shown the posibilities of reverse engineering life-forms from their 
genetic code.
TX-TL can also be used to build sensors and diagnostics devices, an example of which is
a recently developed paper-based Ebola test created at Boston University. This system 
utilizes an RNA responsive toggle switch which produces a red marker in the presence of
Ebola RNA and green in its absence. By freeze-drying the circuit DNA together with 
TX-TL extract and buffer, the whole circuit can be stored in a filter paper and used for 
cheap and versatile diagnostics [23], [24].
There are also commercially available cell free expression systems, which can be used for
other purposes than circuit prototyping, often aimed at high yield protein synthesis for 
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purification.
In the 'Murray biocircuits lab' at Caltech, several complex biocircuits have been 
developed by prototyping parts and modules in the cell-free TX-TL environment [25], 
[26]. The ongoing projects strive to create circuits with more complex functions that 
involve a high number of parts and modules. One milestone is to be able to rapidly 
prototype circuits consisting of 8-16 promoters in a matter of weeks. The reduced 
complexity of the TX-TL environment also simplifies computer modeling of biocircuits, 
which has enabled the creation of a MATLAB-based modeling toolbox that allows 
testing of circuit logic in silico (see section 1.6).
1.5. Cloning and DNA assembly
Every DNA construct in a biocircuit needs to contain a certain set of DNA parts to 
functionally fill its role in the circuit. The following parts are typically included in 
constructs:
● Promoter (P): allows for transcription of the DNA by providing binding sites for 
RNA polymerases (RNAP).
● Untranslated region (U): allows for translation of RNA by proving a binding site 
for ribosomes (therefore also called RBS – ribosomal binding site).
● Coding sequence (C): provides the code to be read by ribosomes and thereby 
determines the amino acid sequence of the final proteins. 
● Terminator (T): stops the transcription of RNA from DNA by forming a hair-pin 
secondary structure which stops RNAP.
To assemble the DNA constructs for a circuit, parts that are compatible with the chosen
assembly method needs to be made (see Figure 4, arrow A). The templates used for part
creation can be plasmids or linear pieces which have been derived from a variety of 
organisms using the tools of bioengineering and genetic modification. These DNA 
templates are then used to amplify the specific sequences needed using standard 
Polymerase Chain Reaction (PCR). For this project, more than 70 parts were created 
and for several of these functionality has been tested.
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To combine the individual parts into constructs (by some referred to as 'cassettes') the 
Golden Braid (GB) method used [27]. The advantage of this method is that it allows for 
several DNA pieces to be combined in one single reaction. This is achieved by having 
the ends of each part tailored so that it forms 'sticky ends' which then bind to the 
complementary DNA sticky ends of other pieces, after being digested by the enzymes 
BsaI or BbsI (Figure 4, arrow B). This forms a sequence of parts that attach to the 
vector backbone to form circular plasmids (Figure 4, arrow C). Construct assembly with
the Golden Braid method is generally fast, compared to other assembly methods, but 
requires a library of compatible parts. While the assembled plasmids can be used to 
transform cells for immediate in vivo testing (Figure 4, arrow E), circuit debugging in a 
cell-free TX-TL system, prior to in vivo testing, is in many cases a far more time-
efficient strategy [8]. The GB products can be used as PCR templates together with 
primers that include some 'junk DNA' to the ends; which helps to protect against DNA 
exonucleases that would otherwise destroy the region of interest during TX-TL construct
testing. The PCR product can be readily used for testing in TX-TL (Figure 4, arrow D),
and sequenced to determine that the correct DNA piece has been assembled. 
The rate at which every DNA construct produces protein is dependent on a vast number
of variables, of which only a few can be controlled with ease. In bacterial cells, the copy-
number of a plasmid gives a rough estimate (low, medium or high) of how many 
plasmids are present within the cell, which depends on how strong the replication of 
origin on the plasmid is. In TX-TL experiments, the concentration of individual 
constructs can be tuned much more precisely to determine the optimal working 
conditions. Since there is no way to fine-tune DNA concentration ratios in vivo, other 
methods are used to change the expression strength of constructs, primarily by altering 
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Figure 4: The process of Golden Braid cloning, from parts creation (A) and construct assembly 
(B&C), to testing in vitro (D) and in vivo (E).
promoter strength, ribosomal binding site (RBS) strength or inducer levels. The 
promoter part of a construct usually has some connection to the logic function of the 
circuit (e.g. it allows for activation or repression by transcription factors), and therefore 
tuning the strength of the promoter is sometimes not practical since it may alter its 
logic function. However, the RBS part of a construct often plays the sole role of 
initiating translation of mRNA, and can thus be changed to allow tuning of construct 
expression strength. By using an RBS of bicistronic design architecture (BCDs), the 
translational strength can be regulated in a predictable manner, with minimal influence 
from the upstream promoter and downstream coding sequence [28].
1.6. Computer modeling
In synthetic biology, like many other engineering disciplines, an interest for solving 
research questions through computer modeling and simulations has emerged with the 
aim of accelerating the progress and minimizing labor intensive lab work. Today there is
only limited capabilities of simulating the vast number of interconnected biochemical 
reactions that occur within living cells. In comparison, the cell-free TX-TL environment 
is a much less complicated system to model, free from cross-talk with cell functions. As 
such, it is far easier to build an accurate but simplified model of the biomolecular 
reactions within a TX-TL experiment, compared to an equivalent model of an in vivo 
experiments [29]. To be able to achieve some predictive capabilities from a model, 
sufficient characterization experiments need to be done to determine some of the input 
parameters for the model. Ideally, a series of fairly simple characterization experiments 
would give the model the data needed to predict the behaviour of a larger circuit based 
on characterized parts and modules.
In an effort to achieve predictive modeling, researchers at 'Murray biocircuits lab' and 
their collaborators have developed a MATLAB toolbox for modeling of reactions in TX-
TL. The 'TX-TL modeling toolbox' [30] is based on the MATLAB add-on SimBiology 
which allows the user to define chemical reactions and sets up ordinary differential 
equations for a system of reactions. This means that every reaction between species in 
the model will be assigned with a rate and the concentrations of species will vary over 
time. This way of modeling takes into account resource limitations and other features 
inherent to the TX-TL environment [8]. Naturally, all starting concentrations and 
reaction parameters in the system cannot be known with exactitude, which inevitably 
becomes a source of modeling error. However, the current toolbox parameters are largely
based on characterization experiments and should therefore have values reasonably close
to reality.
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With increasing characterization data and growing knowledge of the mechanisms of 
biomolecular systems, predictive modeling holds the promise of accelerating synthetic 
biology research by shortening design iteration time. It will also allow researchers to 
theoretically explore questions that are otherwise too labor intensive to work with 
experimentally [31].
1.7. Project aims
The goal of this project has been to use the method of rapid prototyping in TX-TL to 
test and design a biocircuit of moderate complexity and characterize the modules that it
consists of. The designed circuit should be possible to clone into E. Coli to enable in 
vivo testing, but the main focus has been on the prototyping and design phase of 
biocircuit development.
The proposed design process for rapid prototyping of biocircuits is as follows: 
Stage 0: Modeling: Simulation of the main circuit and its modules.
Stage 1: Component prototyping: TX-TL implementation of the circuit constructs.
Stage 2: Component assembly: TX-TL implementation of the circuit using plasmid 
DNA.
Stage 3: In vivo implementation of the circuit: Transform cells with circuit plasmids.
Stage 2 and 3 were never reached during the project time and is therefore not described 
in detail in this report.
1.8. Circuit Designs
Finding a circuit design that allows for rapid prototyping and which satisfies the project 
aims requires great knowledge and planning. For this project, several different designs 
were proposed and evaluated from a theoretic stand-point. The main one is described 
here.
1.8.1. Circuit design B: Attenuator-controlled NOR-gate
The Attenuator-controlled NOR-gate was designed to explore how AND-gate modules 
could be controlled from stacked layers of repression. This circuit, shown in Figure 5, 
uses the repression from TetR and LacI to control the production of two antisense 
mRNAs (Anti 1 & 2) which subsequently attenuates the two AND-gate proteins NRI 
and NRII. The background of each of these circuit parts will be explained in this section.
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The proposed AND-gate module comes from the nitrogen regulatory system of E.Coli 
and uses the pGlnA promotor which is activated by the presence of phosphorylated NRI
(Nitrogen Regulator One), denoted NRI-P. The promoter is used within bacterial cells 
to regulate certain nitrogen-related metabolic pathways (such as glutamine synthetase) 
and is controlled by the nitrogen-limitation sigma factor; σ54 (sig54). When nitrogen-
deficiency occurs within the cell, the kinase NRII will get phosphorylated by consuming 
ATP, and subsequently it can phosphorylate NRI which then activates the pGlnA 
promoter (Figure 6). NRI-P degrades over time (half-life measured in vitro to 3.5 min) 
to unphosphorylated NRI, which means that the NRII kinase needs to consistently 
consume ATP to keep the promoter activated [32], [33]. With sigma factor 54 naturally 
occurring in cells under the right conditions, this module forms a logic AND-gate, since 
both NRI and NRII are needed for activation.
14
Figure 5: Circuit diagram for the 'Attenuator-controlled NOR-gate' in its original design 
proposal. The circuit consists of an AND-gate module based on the nitrogen regulator promoter 
pGlnA and a stacked layer of repression from antisense 1 and 2 followed by an inducible 
repression from TetR and LacI. The circuit output can be controlled with inducers aTc and 
IPTG in accordance with the truth table to the right.
To control this AND-gate
module, the design uses
attenuator-antisense pairs to
repress the production of NRI
and NRII. Premature
transcriptional termination
occurs when antisense mRNA
binds to attenuator mRNA
from the ongoing transcription
of a construct. The antisense-
attenuator interaction forces
the mRNA strands into a
downstream hair-pin loop
which blocks RNAP from
continuing transcription along
the DNA strand and eventually lead to termination when RNAP breaks off [34]. Thus, 
when antisense mRNA is transcribed it can interact with the transcription process of 
constructs containing the corresponding attenuator region, and lead to premature 
termination and decreased expression from those constructs. 
To control the antisense production, an additional layer of repression from TetR and 
LacI (Figure 5, top) is used. Since TetR and LacI respond to the inducers 
anhydrotetracycline (aTc) and Isopropyl-b-D-thiogalactopyranoside (IPTG) respectively,
the circuit can be controlled with these inducers levels. These stacked layers of 
attenuation and repression is expected to give the circuit a NOR-gate logic where either 
aTc or IPTG will sequester the deGFP output (see circuit truth table in Figure 5).
1.8.2. Alternative AND-gate modules: pipaH and pSicA
AND-gate modules, such as the pGlnA system, can be found in other regulatory 
functions within cells. The Four-input AND-gate (Figure 2) uses three different 
promoters which are activated by a combination of two or more proteins interacting. 
These AND-gate modules were gleaned from type-III secretion systems (T3SS) of three 
different bacterial strains; Shigella flexneri (pipaH), Pseudomonas aeruginosa (pExsC) 
and Salmonella typhimurium (pSicA). The pipaH and pSicA AND-gate systems are 
based on transcription factors which form complexes with dimers of a smaller chaperone 
protein. The transcription factor-chaperone complexes can bind to, and thereby activate,
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Figure 6: Transcription regulation of nitrogen-regulated 
genes by NRI-NRII. NRII consumes ATP, and the resulting 
NRII-P can phosphorylate NRI into NRI-P which activates 
certain promoters. Reprinted with permission from Heeswjik
et al [46]. 
their respective promoters. AND-gate orthogonality to one another, and an increased 
dynamic range of the modules, was accomplished by editing the different DNA 
sequences, resulting in excellent in vivo performance for all three of the AND-gate 
modules [13]. These T3SS also involve other proteins which can bind the chaperones and
inhibiting the activation [35], [36], but for the purpose of prototyping the pipaH and 
pSicA AND-gates, the full range of T3SS proteins were not needed.
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2. Methodology and materials
The following sections aim to describe the methods used to go through Stage 0: 
Modeling and Stage 1: Component Prototyping of the rapid prototyping process. This 
involved building a parts library, in vitro cloning of constructs using the Golden Braid 
(GB) method, linearizing GB products through PCR reactions, and finally conducting 
TX-TL experiments using linear DNA. In addition, several TX-TL extracts were made 
and characterized.
2.1. TX-TL modeling toolbox
Computer modeling was done using the 'TX-TL modeling toolbox' [30] (trunk166), a 
MATLAB package based on the add-on SimBiology that allows for simulation of 
biocircuit designs (see section 1.6). All simulation runs were made with no native 
repressors (such as LacI) present, and with a virtual 'gamS' concentration of 20 μM. 
MATLAB 2014a was used.
2.2. TX-TL extract making
In order to run biocircuits in vitro, an extract containing the necessary transcription and
translation machinery is needed. This TX-TL extract is made from bacteria cultures and
processed through several steps to make an extract which is free of endogenous DNA but
rich in enzymes that transcribe RNA from DNA, and translate proteins from RNA. 
Since this extract is derived from living bacteria, and due to the many processing steps, 
there may be great batch-to-batch variability. This could be due to cell growth 
conditions, the various cleaning processes, the cell lysis method and the particular 
bacteria strain used. This section aims to summarize the process of extract making, 
which followed a modified version of [37] that uses a homogenizer to lyse cells instead of 
bead beating.
To produce a well performing TX-TL extract, a healthy bacteria culture was needed. 
Mini-cultures were started by picking a single cell colony from a plate containing the 
desired bacteria strain and placing it in 4 ml fresh LB media containing nutrients and 
antibiotics which the particular strain was resistant to (typically Carbenicillin or 
Chloramphenicol). These cultures were grown for 5-8 hours at 37°C before 100 μl were 
transferred into conical flasks with 50 ml media and grown for another 8 hours in 37°C. 
In the final growth step, 6 ml of the cell culture was transferred to 4L conical flasks with
600 ml of LB media and 12.5 ml 50% glucose. Cells were grown for 4 to 7 hours at 37°C,
until the liquid reached OD600 = 3. The incubation was then stopped to ensure that 
cells did not get effected by resource limitations in the media and leave the 'log-phase' 
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growth state. To extract the cells from the remaining media, the cultures were 
centrifuged at 5000 G for 12 min at 4°C, and the supernatant was decanted. The 
remaining cell pellets were cleaned by adding 200 ml of S30 buffer, dissolving the pellet, 
centrifuge for 12 min, and removing the supernatant. The cleaning steps were repeated 
twice before the remaining pellet was stored at -80°C.
On the day of extract making, the cell pellets were thawed on ice and re-suspended by 
adding 1 ml of S30 buffer per 1 g of pellet and vortexing. A homogenizer was used to 
lyse the cells and the resulting liquid was centrifuged at 12000G for 10 min at 4°C. The 
supernatant was transferred into a falcon tube and put in 37°C for run-off incubation. 
The run-off time was varied between 0 and 200 min to test the effect of this processing 
step. The extract was then centrifuged once more and the supernatant (the ready 
extract) was transferred into smaller tubes and flash-frozen in liquid nitrogen for long 
term storage.
2.3. Golden Braid (GB) cloning and PCR
PCR was done to amplify the parts needed for GB assembly, and to linearize the 
assembly product. All reagents were sourced from New England Biolabs® (NEB). The 
PCR reactions used 0.5 to 10 ng of template DNA and otherwise followed the protocol 
for 'NEB Phusion® Hot Start Flex 2X Master Mix' as described by the manufacturer 
[38]. A 'Bio-Rad C1000 Touch Thermal Cycler' was used to control temperatures in 
both PCR and GB reactions.
After PCR amplification of linear parts, the products were DpnI digested by adding 1 μl
of 'NEB DpnI Enzyme' and incubating in a water bath at 37°C for 2 hours to completely
digest remaining methylated DNA. All PCR products were purified using 'QIAquick 
PCR Purification Kit' from Qiagen. The final DNA concentration was measured using a 
'Nanodrop 2000' from Thermo Scientific. The accuracy proved to be dependent on the 
volume used for measuring, and for most concentrations measurements 2 μl (which gave 
more stable reads) was used rather than 1 μl.
Golden braid assembly was done using DpnI digested and purified DNA parts that were 
diluted so that 1 μl of each part gave equimolar amounts of DNA to 50 ng of vector 
backbone. The process for GB assembly followed the protocol described in Appendix
7.2.1. When linearizing GB product, 1 μl of the product was used as PCR template. 
Some of the templates and primers needed for parts creation were already available in 
the lab, but many primers had to be designed and ordered as oligos from Integrated 
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DNA technologies (IDT). Primer design was facilitated by Geneious 7 (software 
package) which also was used to organize all DNA sequence files of parts and constructs.
To systematically organize the parts, a letter and number was assigned to each part (e.g.
the prOR1OR2 promoter used was designated 'P33') to properly distinguish them from 
other promoters with similar names. Following the naming convention for the parts 
library, every construct was assigned a number, preceded by an 'A' (for 'Assembled 
construct'), e.g. A50: pGlnA--UTR1--deGFP--T500 : P67—U32--C41--T11. During this 
project over 80 constructs were assembled, and the majority was used in different part of
the project. All the constructs needed for the parts testing and circuit prototyping were 
made using the GB method, except constructs A66, A67, CH81 and CH92 which were 
made using Gibson assembly prior to the start of this project. 
2.4. TX-TL experiments
Experiments with the cell-free TX-TL system largely followed a protocol developed at 
the 'Murray biocircuits lab'. Purified PCR products of linear DNA were used in all TX-
TL experiments, with the sole exception of the standard 'positive control' (PC) plasmid 
which was added at 1 nM final concentration for experiment verification. To avoid linear
DNA degradation by extract native RecBCD enzyme, 3 μM of the RecBCD-inhibiting 
protein 'gamS' was included in the TX-TL master mix (consisting of extract and buffer).
 
DNA solutions and inducers were mixed in 500 μl tubes at ratios determined using a 
TX-TL calculations spreadsheet [39] prior to adding the TX-TL master mix consisting of
extract and buffer. Proper mixing was achieved by flicking the tubes or quickly 
vortexing before spin-down with a desktop centrifuge. 10 μl of reaction mixture was 
transferred to each well in a 384 well plate which was then sealed with a protective 
plastic film. Typically the content of each tube was divided into two wells creating two 
repeat measurements from which a mean could later be calculated. After spin down of 
the 384 well plate at 2000 rpm for 10 seconds, the plate was placed in a 'BioTek Synergy
H1 Hybrid Multi-Mode Microplate Reader' [40] to measure the green fluorescent protein 
production (gain: 61) from each well over at least 8 hours. Measurement temperature 
was held at 29°C. Data collected from TX-TL experiments were processed using 
'LibreOffice Calc' and 'OriginPro 9' to produce graphs.
2.5. Transformations and plasmid purification
Construct that had been successfully used in circuit prototyping were selected for cell 
transformation and colony screening. Z-Competent (from Zymo Research) chemically 
competent cells were exposed to 5 μl of GB product following the recommended 
transformation protocol. After overnight growth, single colonies were picked and used 
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for colony PCR to screen for transformed cells with the correct plasmid. Colonies which 
displayed the correct band were grown to make glycerol stocks and to purify the 
construct plasmids.
Purified linear DNA and plasmids were used for sequencing together with primers 
according to the guidelines from the sequencing company; Eurofins Genomics. The 
sequencing tubes were bar-coded and sent to Eurofins for DNA sequencing and the 
results were analyzed with Geneious 7.
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3. Results and discussion
This section will describe the results from prototyping various circuit modules to 
gradually build up the designed circuit. Six different TX-TL extracts have been used 
during this project. The extracts mainly differ in the lysis methods and the bacteria 
strain used, which is summarized in Table 1.
Table 1: The TX-TL extracts used during this project and their respective bacteria strain
and lysis method. *Run-off used indicates how long the incubation time was for the 
extract used in subsequent TX-TL experiments, see section 3.1 for more details.
Name Cell strain Lysis method Maker Run-off used* /min 
Es1 BL21rosetta Homogenizer Clare Hayes 40-120 (mix)
Es2 BL21rosetta Homogenizer SURF14 students 120
Es3 BL21rosetta Homogenizer SURF14 students 120
Es4 DH5-alpha Homogenizer SURF14 students 40
Es5 ExpressIQ Homogenizer Zachary Sun 80 (20+60)
eZS3 BL21rosetta Bead-Beating Zachary Sun 80
3.1. Characterization
For each extract, a buffer solution was made by calibrating Mg2+ and K+ concentrations 
for maximum expression with a high-expressing 'positive control' (PC) plasmid. 
Additionally, experiments were designed to determine the optimal time for the 'run-off' 
process step. This processing step, where extract is placed in a shaker at 37°C (see 
section 2.2), is known to increase the signal from extracts, but the process by which this 
is achieved is largely unknown. The run-off time experiments for extracts Es1, Es3, Es4 
and Es5, where each run-off time point was tested with the control plasmid and 
fluorescence at t=480 min was recorded, is shown in Figure 7. Extract Es2 was 
determined unsuccessful since it consistently produced fluorescence lower than 100 RFU 
at gain 61 for all run-off times. eZS3 was made prior to the start of this project and 
could therefore not be included.
The results show that there was an optimal run-off time for each extract which yielded 
an up to 4.5 times higher signal than before the run-off incubation. While all three 
extracts benefit from the first 40 minutes of run-off incubation, the effect of prolonged 
incubation seems to have little or adverse effect on extract performance. To determine 
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whether the optimal run-off time is a function of cell strain, growth condition or 
processing methods, this experiment would have to be replicated over a large number of 
extract batches.
3.1.1. Repressor-inducer characterization
Es5, based on the ExpressIQ strain, proved to give highest signal and was therefore used
for further circuit prototyping. A 'C1-cassette' in the ExpressIQ genome makes it 
constituively produce LacI repressor protein, so experiments were carried out to 
determine the native LacI repression in the extract. Figure 8 shows the deGFP 
production from increasing concentration of reporter constructs with the pLac and pTet 
promoters respectively (top graphs). The signal from the pTet reporter is approximately 
six-fold of that of the pLac reporter, which can be explained by the extract native LacI. 
The bottom graph of Figure 7 shows the effect of adding repressor producing constructs,
A55 or A53, to 7 nM of the reporter constructs A71 and A46 respectively. As expected, 
the repressed deGFP signal (orange bars) could be regained by adding inducers aTc and 
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Figure 7: Data from run-off experiments with extract batches Es1:BL21ros:h, Es3:BL21ros, 
Es4:DH5a:h and Es5:ExpIQ:h. The optimum run-off incubation time varies between extracts. 
Es5 data is from single repeats, hence no error bars are shown.
IPTG, respectively. In the pLac case (A46), additional IPTG also binds to the extract 
native LacI, hence the de GFP concentration goes up beyond the 'reporter only' level 
(blue bar). The signal from the pTet reporter (A71) was only regained to approximately 
78% of the 'reporter only' case when the highest concentration (10 μg/ml) of aTc was 
used. This shows that all the expressed TetR dimers cannot be bound to aTc, even with 
relatively high inducer concentrations. Since aTc exhibits some fluorescence on its own, 
a negative control with equal concentration of the inducer was subtracted from the 
measured deGFP signal in the experiments where aTc was used.
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Figure 8: Characterizing TetR and LacI repression to determine construct functionality and the 
extract native LacI repression. The top graphs show how increasing reporter concentration leads 
to higher output deGFP in the absence of A55 and A53. Bottom graphs show how the presence 
of TetR and LacI lowers the deGFP levels, which can then be regained by increasing the inducer
concentration with aTc and IPTG respectively. (* Without native LacI in the extract, the logic 
would be identical to the TetR repression).
These characterization experiments of extract Es5 shows that simple repressor and 
inducer functions behave as expected and that the extract expression was sufficiently 
high to be used for further circuit prototyping.
3.1.2. Tuning expression strength with ribosomal binding sites
To evaluate how gene expression can be tuned by the strength of its ribosomal binding 
site, four of the bicistronic designs (BCDs) from Mutalik et al. [28] were used to 
assemble reporter constructs. These reporters were benchmarked against a reporter with 
the lab standard 'UTR1' in a TX-TL experiment. The tested constructs were:
A36: prOR1OR2--UTR1--deGFP--T500 : P33--U32--C41--T11
A37: prOR1OR2--BCD2--deGFP--T500 : P33--U17(zs)--C41--T11
A5: prOR1OR2--BCD1--deGFP--T500 : P33--U35--C41--T11
A38: prOR1OR2--BCD18--deGFP--T500 : P33--U43--C41--T11
A39: prOR1OR2--BCD8--deGFP--T500 : P33--U46--C41--T11
When compared in TX-TL, the constructs show the same general pattern of RBS 
strength as describe in the original paper, as shown in Figure 9. The lab standard 
'UTR1', which is not of BCD type, is known to give strong translation and is closely 
followed by BCD2 in RBS strength. Notably, the data from Mutalik is from in vivo 
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Figure 9: The deGFP expression can be modulated by changing the ribosomal binding site. 
To the left, four different BCDs were compared to the lab standard 'UTR1' and a positive 
control (PC) plasmid (shown in gray). Measured at t=420 min. All linear DNAs were at 10 
nM concentration. *A5 (BCD1) data was from a separate run and has been normalized to the
level of PC expression in that experiment.
To the right; adapted from Mutalik et al [9] and reprinted with permission. Heat-map of GFP
expression for different combinations of promoters (columns) and BCDs (rows). The BCDs 
show predictable translational strength over a wide range of promoters. 
experiments, but the in vitro TX-TL experiments gave a fairly similar pattern of RBS 
strength.
3.2. Circuit design B: Attenuator-controlled NOR-gate
The atteunator-controlled NOR-gate was chosen for prototyping with TX-TL 
experiments, for which the results will be presented in this section.
3.2.1. AND-gate 1: pGlnA with NRI, NRII and sig54
The first module to be tested was the pGlnA AND-gate. As previously described, the 
module should only activate in the presence of sigma 54 and phosphorylated NRI (which
requires the kinase NRII to phosphorylate it). The pGlnA construct (A50), was tested 
with NRI (A61), NRII (A62) and sig54 (A63). All constructs were assembled with the 
GB method.
A50: pGlnA--UTR1--deGFP--T500 : P67--U32--C41--T11
A61: prOR1OR2--UTR1--NRI--T500 : P33--U32--C56--T11
A62: prOR1OR2--UTR1--NRII--T500 : P33--U32--C57--T11
A63: prOR1OR2--UTR1--sig54--T500 : P33--U32--C58--T11
In contrast to what previous work has
found, the first test shows that the
promoter was active even without
adding DNA coding for sigma 54
(Figure 10). Furthermore, the signal
dropped when 2nM of A63 was added.
Sequencing of the linear DNA
construct A50 showed that the pGlnA
promoter sequence was intact, but
A63 sequencing did not give a
comprehensive read, which could be
an indication of a failed DNA
assembly. The permanent activation
of A50 could be due to residual
sigma54 and NRI-P (and possibly
NRII) in the extract. Extracts
produced with the bead-beating
method from cells under slightly
different growth conditions has shown
to not contain significant amounts of
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Figure 10: The pGlnA promoter on construct A50 is
active even without the presence of DNA coding for
NRI, NRII and sigma54. Surprisingly, the 
introduction of A63 results in lowered deGFP 
signal. Shaded areas show the signal from the two 
repeats in the experiment (std), and the mean is 
shown as lines.
sigma54 [41]. However, with a different growth protocol and lysis method, the extract 
used for these tests (Es5) could possibly contain some or all proteins needed to activate 
pGlnA. Further testing, possibly in different extracts, could be done to resolve this 
question.
When A61 and A62 were introduced to the system, the initial rate of deGFP production
increased, but the added DNA load made the GFP production stop earlier (Figure 11). 
The experiments were done for both 10 nM and 20 nM of the reporter construct; A50. 
From the data, a time derivative was taken using the 'differentiate function' in 
'OriginPro 9' with an applied Savitzky-Golay smooth filter (poly-order: 2, Points of 
window: 20). In Figure 11, the right hand graphs show the first derivative of the deGFP
signal which reveals that the rate of production from the pGlnA promoter is indeed 
higher when A61 and A62 are added, compared to the case with A50 only (with or 
without A63).
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With an increasing amount of DNA in the system, it has been shown that resources such
as NTP and amino acids gets consumed more rapidly [8], which explains the early stop 
in deGFP production when adding more of A61 and A62. Therefore, a more interesting 
metric when analyzing this AND-gate module might be the peak rate of deGFP 
production since resource limitations are less dominant during the initial phase of the 
TX-TL run. To correlate the experiment to in vivo function, the peak rate might also be
a more suitable metric because resources are generally replenished in living cells, giving 
less pronounced loading effects.
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Figure 11: Prototyping experiment of the pGlnA AND-gate module. The deGFP production 
rate increases when A61 and A62 were added. However, the production stops at an earlier time 
which indicates that resource limitations greatly effected the experiment. Shaded areas on line 
plots show the standard deviation of two wells within the same experiment.
In Figure 12, the peak rate of production from 10nM of A50 is shown over the 
concentration space of A61 and A62. This clearly displays that the promoter activation 
and resource loading both come into play resulting in an optimum working 
concentration point at 4 nM A61 and 14 nM A62. Overall, the functionality test of this 
AND-gate module shows that it can be activated to some degree, but it lacks a proper 
OFF-state. It is highly possible that the module would function differently in vivo, or in 
extracts prepared with different protocols, since previous lab experiences suggest this. 
More experiments would be needed to determine this. 
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Figure 12: Mapping out the concentration space to find a optimum activation of the pGlnA 
promoter without putting heavy resource loads on the system. The highest peak rate of deGFP
production is reached with 4 nM of A61 and 14 nM of A62. 
3.2.2. AND-gate 2: pipaH with mxiE and ipgC
Since the results of the TX-TL testing of the pGlnA AND-gate module did not show a 
very convincing AND-gate logic, alternative AND-gate modules were considered. The 
Shigella system from Moon et al [13], with the transcription factor mxiE binding to the 
chaperone protein ipgC to activate the promoter pipaH, was chosen for initial TX-TL 
testing. 
Coding sequences for mxiE and ipgC, and the promoter sequence for pipaH (the 
modified sequence denoted pipaH* in the original paper), where extracted from the 
original Moon et al plasmids, and the necessary GB ends were added. This allowed for 
three test constructs to be assembled;
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Figure 13: TX-TL testing of the pipaH promoter with varying concentrations of DNA coding 
for transcription factor mxiE and chaperone ipgC. Promoter activity is low in presence of only
one of the proteins, but up to 50-fold higher when both mxiE and ipgC are present. 
A72: pipaH--UTR1--deGFP--T500 : P73--U32--C41--T2
A74: prOR1-OR2--UTR1--ipgC--T500 : P33--U32--C71--T2
A75: prOR1-OR2--UTR1--mxiE--T500 : P33—U32—C72--T2
After PCR amplification, the linear DNA constructs were tested in TX-TL using a 
constant reporter concentration (10 nM of A72) but varying the concentration of the 
mxiE and ipgC producing DNA pieces (0 to 10 nM of A74 and A75). The result, shown 
in Figure 13, shows a very low leakiness from the pipaH promoter and strong activation 
when both mxiE and ipgC are present (50-fold difference after 400 min).
Loading of the TX-TL machinery is believed to be the cause for the drop in signal when 
adding 10 nM of A75, compared to the higher signal for both cases with 4 nM of A75. 
To reach the highest possible activation of 10 nM pipaH reporter, a A75 concentration 
lower than 10 nM should therefore be used. The optimal A74 concentration appears to 
be 10 nM but an eventual signal plateau was never quite reached, meaning that an even 
higher concentration of A74 could result in even stronger promoter activation. 
30
Figure 14:  GFP signal from linear pipaH reporter construct (A72), t=400 min, shown over the 
A74-A75 concentration space. To the left: Experimental data (from Figure 12). To the right: 
Modeling results of the same setup using parameters tuned to fit the experiment. In Appendix
7.3.1, the full modeling result of the concentration space is shown as a 3D surface.
The characterization of the pipaH module gave sufficient data to allow for a model to be
created with the TX-TL MATLAB toolbox. The system parameters, such as the mxiE-
ipgC binding rate, were tuned to fit the experimental data. As seen in Figure 14, the 
parameters could not be tuned to fit the experiment exactly and the magnitude of 
deGFP output was roughly 2.1-fold lower in the model, compared to the experiment. 
Naturally, there should be a parameter set for the model that more accurately fits the 
experimental data, but with a large muti-dimensional parameter space of reaction 
variables, the ideal parameter set is hard to obtain without using sophisticated search 
algorithms. This model was later used to step by step build the complete circuit and 
predict the responses, see section 3.2.5. 
Figure 15 shows the rate of fluorescence increase, which can be used to compare pipaH 
activation with pGlnA activation. It is apparent that the fold change in rate for pipaH is
much greater than that from pGlnA. The concentration space plot for pipaH also looks 
very similar to the end-point measurements which shows that end-point measurement is 
proportional to the rate in this case. 
All in all the TX-TL prototyping of the pipaH AND-gate shows excellent ON/OFF-ratio
and a strict AND-gate logic which makes it a suitable replacement for the pGlnA system
in the main circuit.
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Figure 15: The time derivative of the fluorescence signal (RFU/min) from the pipaH TX-TL 
testing. The promoter is greatly activated in the presence of mxiE and ipgC, reaching a peak 
production after approximately 50 min. For comparison, the positive control plasmid at 1 nM is 
included in dashed gray. To the right, the peak rate is shown over A74-A75 concentration space.
3.2.3. Attenuator-antisense pairs
The next layer in circuit design B uses attenuator-antisense pairs to control the input to
the pipaH AND-gate. To prototype this in TX-TL, several new construct were 
assembled and their linear DNA was amplified to sufficiently high concentrations. The 
constructs used for funtionality testing were:
A66: pJ23119--anti1--TrrnB : JBL004 (Directly linearized from pre-made plasmid)
A67: pJ23119--anti2--TrrnB : JBL008 (Directly linearized from pre-made plasmid)
A59: prOR1OR2--att1--deGFP--T500 : P33--U4s--C41--T11
A60: prOR1OR2--att2--deGFP--T500 : P33--U5s--C41--T11
First, the functionality of the attenuator parts (att1 and att2) by the antisense parts 
(anti1 and anti2) was tested. This was done by combining antisense constructs that had 
previously been tested (JBL004 and JBL008), with the untested attenuator constructs 
(A59 and A60). The results, shown in Figure 16 suggest that some attenuation effect is 
present, since the signal decreases when the correct antisense-attenuator pairs were 
combined.
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From these tests it can be concluded that the attenuator constructs A59 and A60 are 
functional, indicating that GB assembly with the attenuators as untranslated regions 
(UTRs) gives functional constructs capable of interacting with the antisense mRNA. For
both attenuator constructs, an increased signal is gained when adding the 'wrong' 
antisense, which was supported by the predictive modeling results. This effect may seem
counter intuitive but can be explained by the loading of RNases from the additional 
mRNA from these construct. By occupying RNases, the deGFP mRNAs in the solution 
are degraded much slower, resulting in a higher output signal. Figure 16 also includes a 
modeling result of attenuator 1 where a lower concentration (200 nM) of RNase was 
used. With 1/4th the RNase in the model, the effects of RNase loading from 27 nM of 
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Figure 16: Functionality test of attenuator-antisense pairs. The top graphs (1) shows the 
attenuator 1 response to the two antisense constructs, and the bottom graphs (2) shows the same 
for attenuator 2. On the right; output from models of the attenuator-antisense experiments. For 
Attenuator 1, the results from a model with a lower RNase starting concentration is included to 
display how the effect of RNase loading can influence the result.
A67 is greatly enhanced, as seen in the large signal increase. The actual RNase 
concentration in the extract is difficult to measure and was not determined in this work.
The RNase loading effect is in competition with the effects of increased DNA loading on 
the TX-TL system. In this first functionality test, RNase loading seems to be the 
dominant effect, but in subsequent tests it was not (see Figure 17). One possible 
explanation is that the concentrations used in this experiment were not measured with 
the same accuracy as in the rest of the experiments and the conditions may therefore be 
slightly different than reported. 
3.2.4. Attenuator controlled pipaH AND-gate
To test the effect of attenuators on the pipaH AND-gate the following constructs were 
used:
A36: prOR1-OR2--UTR1--deGFP--T500 : P33--U32--C41--T2
A72: pipaH--UTR1--deGFP--T500 : P73--U32--C41--T2
A74: prOR1-OR2--UTR1--ipgC--T500 : P33--U32--C71--T2
A75: prOR1-OR2--UTR1--mxiE--T500 : P33--U32--C72--T2
A91: J23119--att1--ipgC--T15 : P68--U4s--C71--T15
A92: J23119--att2--mxiE--T15 : P68--U5s--C72--T15
A66: pJ23119--anti1--TrrnB : JBL004
A67: pJ23119--anti2--TrrnB : JBL008
To be able to separate the effects of DNA loading from the actual attenuator-antisense 
interaction, the two antisense constructs (A66 and A67) were tested on A36, 
A72+A74+A75 and A72+A91+A92, as shown in Figure 17 (circuit diagrams A to C). In
the first two cases (A and B), there should be no attenuation from the antisense mRNA 
since none of the constructs contain either of the two attenuator regions. The top row of
graphs in Figure 17 shows how the addition of antisense DNA lowers the deGFP signal 
for all three cases with case 'C' having the largest decrease. This was an expected result 
since 'C' will be affected both by DNA loading and by the antisense attenuation of the 
AND-gate constructs A91 and A92, while A and B will be affected by DNA loading 
only.
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Figure 17: Testing the effect of antisense coding DNA on the expression of a downstream AND-
gate module. To control for TX-TL loading, a simple reporter construct (A) and a attenuator-
free AND-gate (B) was used. The attenuator controlled sub-circuit (C) is supposedly effected by 
both loading and attenuation from antisense mRNA. t=300 min.
In the bottom graphs, the decrease as compared to the highest signal (orange bars in 
upper graphs) is illustrated for all three data sets. The decrease in signal with A36 is 
consistently smaller than the decrease for the two AND-gate cases since 'A' contained 4 
nM less DNA and the reporter does not need any transcription factors to be activated. 
In the two AND-gate cases, the two-step process (production of ipgC and mxiE first, 
followed by deGFP production) is greatly effected by the increased loading, thus there 
was no significant difference in the decrease between 'B' and 'C' when adding 20nM of 
both A66 and A67. However, when adding 20 nM of either A66 or A67 the attenuator 
controlled AND-gate (with A91+A92) decreases significantly more than case 'B'. 
Assuming that DNA loading is solely
responsible for the decrease in 'A' and
'B', the decrease from adding 10nM
each of A66 and A67 can be estimated
as the mean between the decrease from
20 nM of either A66 or A67. However,
for C it is apparent that the addition
of 10 nM A66+A67 results in a
decrease slightly greater than the
mean of the two cases with 20 nM of
either A66 or A67. This suggests that
attenuation of both the ipgC and the
mxiE production is more effective, in
decreasing the activation of the pipaH
promoter, than stoping the production
of only one of these AND-gate
proteins.
A model was built to fit the
experiment with case 'C' using the
parameters tuned to fit the previous
experiments with pipaH and
attenuator-antisense pairss. The result in Figure 18 shows a circuit response close to the 
experiment with signal decreases of at least 92% upon addition of antisense coding DNA.
As previously mentioned, the model does not fully encompass the effect of DNA loading,
hence the signal decrease in the model is manly due to the antisense attenuation effect.
To be able to test the next circuit layer in TX-TL, attempts were made to make 
antisense construct which could be controlled by repressors TetR and LacI. However, 
these attempts were largely unsuccessful, partly due to the high DNA concentrations 
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Figure 18: Modeling result of antisense controlling 
the pipaH AND-gate. The result should be 
compared to Figure 17, circuit C. The model uses 4
nM A72 and 2 nM each of A91 and A92.
needed to fit all the relevant circuit constructs in the reaction solution. Results from this
can be found in Appendix 7.3.2.
3.2.5. Modeling of complete circuit
The complete 'Attenuator-controlled NOR-gate'-circuit was never successfully assembled
in a TX-TL experiment. Instead, the modeling toolbox was used to predict the circuit 
logic at different stages. 
A concentration of 6 nM of each of the antisense constructs was deemed to give a 
sufficient signal attenuation (as seen in Figure 17) and was used for further modeling. 
To determine the optimal working concentrations of TetR and LacI expressing 
constructs ('DNA TetR' and 'DNA LacI') a grid of simulations was made with varying 
concentrations of the two DNA constructs. Figure 18.A shows that much of the signal 
can be regained when adding the two repressor coding DNAs (compare (0,0): 42 nM 
deGFP to (2,2): 412 nM deGFP). However, when to much DNA is added the signal 
drops due to DNA overlading the system (e.g. (7,7): 252 nM deGFP). At this stage of 
the circuit, a clear AND-gate logic is displayed, where the precence of only one of the 
repressors (TetR or LacI) is not enough to significantly increase the signal since only one
of the two AND-gate proteins will be expressed in abundance in these cases.
With fixed concentrations of 2 nM each of 'DNA TetR' and 'DNA LacI', the full circuits
reponse to inducer levels could be modeled, as shown in Figure 18.B. When either aTc 
(TetR-inducer) or IPTG (LacI-inducer) are introduced, the repression on either of the 
antisense constructs is lifted and the resulting antisense mRNA attenuates the 
expression of the AND-gate proteins. The signal decrease is largest when both of the 
inducers are at high concentrations, which for TX-TL experiments mean up to 10 μM 
aTc (= 4.6 μg/ml) and 500 μM IPTG. These inducer concentration levels result in a 8-
fold decrease in signal (compare (1,1): 411 nM deGFP to (10000,10000): 51 nM deGFP).
Such a fold-change in deGFP expressino would be readily detectable in a TX-TL 
experiment, provided that the signal-to-noise ratio is sufficiently high. The full circuit 
exhibits a clear NOR-gate laogic, as anticipted when designing the circuit. 
It remains uncertain how well this circuit model relates to a real circuit assembled in 
vitro or in vivo. In TX-TL, the effect of DNA loading would most likely bring doen the 
overall signal, resulting in a smaller fold-change response. In cells, where resources are 
continously replenished, the loading effects are expected to be less dominant. However, 
the inherent possibility of cross-talk with cell functions might effect the circuit 
performance.
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3.3. AND-gate 3: pSicA with invF and sicA
To test the pSicA AND-gate module, which had the largest dynamic range according to 
'Four-input AND-gate'-paper by Moon et al, the DNA parts had to be extracted from 
the original plasmids. The promoter, pSicA, and the chaperone CDS, sicA, were PCRed 
up using newly designed primers, while the transcription factor CDS, InvF, had to 
undergo extra cloning to make it compatible with GB assembly (see inlet). 
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Figure 19: Modeling of the complete 'Attenuator-controlled NOR-gate'. A: Modeling of the 
circuit with varying repressor concentrations to find an optimal repression levels. B: The full 
circuit response to inducers aTc and IPTG. The model predicts an 8-fold change in deGFP 
expression from the circuit. In Appendix 7.3.3, the result of 'A' is provided from a different angle
and as a heat-map.
The newly developed parts were used to make three test constructs that were linearized 
for rapid TX-TL prototyping:
A104: pSic--UTR1--sfGFP--T16 : P75--U32--C83--T16
A105: prOR1-OR2--UTR1--sicA--T16 : P33--U32--C85--T16
A118: prOR1-OR2--UTR1--InvF--T16 : P33--U32--C86--T16
 
The concentrations of the transcription factor construct, A118, and the chaperone 
construct, A105, were varied from 0 nM to 6 nM, while the concentration of the reporter
construct, A104, was kept constant at 6 nM. The result, using extract Es5, is shown to 
the left in Figure 20. An ON/OFF ratio of 740 can be seen from the (0,0) case to the 
highest expressing cases, and the off-states signals were low, ranging from 39 to 435 
RFU at gain 61. To investigate the effect of using different extract preparation methods,
the bead-beating extract eZS3 with corresponding buffer bZS3 was used for a replicate 
experiment. The results from this second run, shown to the right in Figure 20, were 
similar to those obtained with homogenizer extract Es5, though the overall magnitude of
signal was about 1/3 lower. Thus it could be concluded that the extract preparation 
method does not greatly effect the functionality of the pSicA module. Compared to the 
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In vitro cloning of a GB compatible InvF coding sequence
The coding sequence for the transcription factor 'InvF' contained cut-sites sequences for both 
of the restriction digest enzymes BsaI and BbsI, making GB assembly with this CDS 
impossible. To remove these cut-sites, a three step process was used. First, primers were 
designed to PCR out three sub-segments of the CDS so that the two cut-sites were removed. 
Secondly, the three segments were merged together in a GB reaction to form a CDS free of 
cut-sites. This was done by designing the first set of primers so that the three segments all got 
compatible GB sticky-ends which merged them together with a vector backbone in the 
reaction.
The edits in the CDS naturally meant that some of the codons in the sequence were altered, 
but by using the E.Coli codon library [45], these alterations could be made so that the codons 
still coded for the same amino acids as before. The end result was an InvF CDS without cut-
sites that in theory should be translated to the exact same protein by the E.Coli translation 
machinery. In the third step, the new coding sequence was PCR from the intermediate GB 
product with primers that added the standard GB compatible ends. This part was used to 
assemble new constructs, such as A118: prOR1-OR2--UTR1--InvF--T16.
After sequencing of linearized A118 containing the new InvF CDS, it was apparent that the 
cloning procedure was successful. TX-TL prototyping of the whole pSicA AND-gate would 
reaveal if the new InvF CDS actually resulted in a protein with the same functionality as 
before the cloning.
pipaH AND-gate, the pSicA module shows an enven greater ON/OFF ratio. The 
activation of the pSicA promoter seems to very drastic as only small additions (0.5 nM) 
of A105 and A118 gives a significant activation.
3.4. Continuation of the project
Additional cloning and TX-TL testing has been done by researchers C. Hayes and T. 
Zhou to further prototype the 'Attenuator-controlled NOR-gate' before eventual in vivo 
implementation in E.Coli. As a first step, the antisense control of the AND-gate was 
tested again using a 'blank' antisense to compensate for DNA loading. This 'blank' was 
a sequence with the same length as the real antisense but without the ability to effect 
attenuator regions in any way. By keeping the total antisense DNA concentration 
constant at 40 nM, the true attenuation effect could be quantified. The results, shown in
Figure 19, confirms that the attenuation works as suggested by the previously presented 
experiments (section 3.2.4).
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Figure 20: Prototyping of the pSicA AND-gate module using two different extracts: homogenizer
extract Es5 (left) and bead-beating extract eZS3 (right). Reporter construct A104 was at 6 nM 
concentration. In Appendix 7.3.4, the same data is shown with rescaled Z-axes to show the level 
of the OFF-states.
3.5. Future work
To finalize the TX-TL prototyping of circuit design B, the complete circuit, further 
attempts to assemble the complete circuit in a TX-TL experiment could be made. 
However, it remains uncertain if such an experiment will give any further insight for 
design improvement since DNA loading effect will be very dominant due to the large 
total DNA concentration. On the other hand, there are extracts that are known to have 
increased expression and overall performance, suggesting that a sufficient signal-to-noise 
ratio could be obtained with lower DNA concentrations and thereby opening up the 
possibility to test circuits of this size. 
Another approach to evaluate the circuit design would be to clone the circuit construct 
onto one or two plasmids and transform cells for in vivo testing of the complete circuit. 
This is generally a time consuming approach due to the several cloning steps and colony 
screenings required. The TX-TL prototyping has led up to some design improvements 
(e.g. swapping out the AND-gate module) and helped in tuning the DNA ratios for some
of the constructs. An in vivo implementation of the circuit is therefore more likely to 
succeed when this new insight is used. 
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Figure 21: Attenuator control of the pipaH AND-gate tested using a blank antisense to 
distinguish loading effects from mRNA attenuation. Concentrations: A72 at 4nM, A91 and A92 
at 2 nM each. Courtesy of T. Zhou and C. Hayes, 2014 (unpublished work)
By confirming the function of the pipaH and pSicA modules in vitro, this work opens up
the possibility to design new circuits for TX-TL testing. As proven by the 
implementation of the 'Four-Input AND-gate' by Moon et al, these modules can be used
to sum the outputs of two sub-circuits. This type of sum function is not limited to the 
outputs of static sub-circuits, such as logic gates, but could also be applied to circuits 
with dynamic responses such as oscillators and pulse generators. Figure 22 illustrates 
how two oscillators (3-node repressilators) could be combined to form an interference 
pattern logic. When the two repressilators are out of phase the two AND-gate proteins 
are not abundantly present at the same time, resulting in no significant reporter 
activation. Eventually, circuits like these could allow for complex patterns of time-
triggered events to be implemented in living cells and further push the boundaries of 
synthetic biology progress.
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Figure 22: Schematic illustration of a potential dual-oscillator circuit. The output of two 
repressilators is combined in a pSicA AND-gate to form a circuit output which depends on the
phase shift of the oscillators. ssrA-tags on each of the proteins assures fast degradation to 
achieve a dynamic response [17]. The purpose of this design is to show the potential use of 
AND-gates in future generation dynamic biocircuits.
4. Conclusions
During this project, three AND-gate modules, two attenuator-antisense pairs and several
circuit motifs combining these elements have been prototyped in a cell-free TX-TL 
system. This has given valuable insight for design improvements and for biocircuit 
designs implementation in general. 
The pGlnA promoter AND-gate testing showed an unexpected leaky signal even in the 
absence of sigma 54, NRI and NRII. Furthermore, the heavy resource loading of the TX-
TL system made the module difficult to evaluate. For assembly of the complete circuit 
in TX-TL, this modules performance was deemed inadequate, but previous unpublished 
work show that the response could be better when working in vivo. Further testing 
would be needed to determine if pGlnA would be functional in this circuit design. As an 
alternative, the pipaH AND-gate module was tested, which showed excellent ON/OFF 
ratio and AND-gate logic, which made it a stronger candidate for further circuit 
development.
Attenuation by antisense mRNA was achieved to some extent, but a large amount (up 
to 10-fold concentration) of antisense DNA was needed to properly sequester the signal. 
When testing these parts, one of the limitations of using a cell-free system became 
apparent as the system became overloaded when more than approximately 30 nM of 
DNA was used in a single reaction. To quantify the effect of attenuator-antisense pairs, 
these loading effect needs to be compensated for. This is best done by introducing a 
'blank antisense' which does not effect either of the attenuators but assures a constant 
DNA load in all experiments, making the attenuation easily measurable. Though this 
approach was not done in the first experiments, later work by T. Zhou et al (see section
3.4) confirmed the results of the initial tests.
In the published literature, no previous attempt of in vitro characterization of Moon et 
al's engineered AND-gates modules, pipaH and pSicA, has been found. Some 
characterization has previously been done with the naturally occurring T3SS system 
components which has revealed their mechanism for gene regulation [36]. However, this 
work introduces the novelty of in vitro characterization of the engineered AND-gate 
variants in TX-TL, and thereby lays the foundation for rapid prototyping of new circuit 
design incorporating these modules.
In a broader sense, this thesis work can serve as a reference for continued development 
of biocircuits using the methodology of rapid prototyping using TX-TL in synergy with 
computer modeling. Regardless of biocircuit design, a rational approach to testing and 
trouble-shooting will be needed to minimize the time and cost of realization. Thus, the 
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rapid prototyping process used in this thesis might be a suitable strategy for future work
in the field.
Designing moderately complex circuits, like the ones proposed in this project, will help 
build towards better control of engineered bacteria and other life forms, as well as give a
better understanding of the processes governing gene expression and biocircuits within 
living cells. This is the spring board needed to accelerate biotechnology to new 
achievements within many different fields, such as medicine, biochemical production, 
drug delivery and gene therapy.
The field of synthetic biology has been advancing steadily over the past years, and with 
some truly impressive technical achievements, the foundation for advancement in the 
field has been laid, piece by piece. With automation replacing manual labor, and a 
growing library of enhanced genetic parts, it is reasonable to think that synthetic 
biology will continue to accelerate over the coming years. Naturally, the new capabilities
raises important questions about the responsibility of manufacturers and labs who 
engineer GMOs. Perhaps one of the mostly widely debated issues in synthetic biology is 
the use of GMOs in agriculture and food production, where concerns have been raised 
about its impact on human health, food safety and ecosystems [42], [43]. As with any 
powerful technology, the risks of implementation has to be weighed against the benefits 
of progress. The power of biological systems can undoubtedly be used to solve pressing 
problems, as illustrated by the paper-based Ebola diagnostics tool (mentioned in section
1.3). Eventually, the extended use of biological systems in technological applications 
may bridge the gap between the in vitro and in vivo world which, if used wisely, can 
help us create a more sustainable future.
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7. Appendicies
7.1. Glossary
Glossary entries are provided for words marked in italics on their first appearance in the
text.
activator – a protein or protein complex which activates the expression from a construct 
by allowing RNAP to bind to the promoter. Some activators require an inducer 
molecule to function.
anhydrotetracycline (aTc) – an inducer molecule which bind the TetR repressor and 
through a conformational change drastically lowers its binding affinity to the Tet 
operon on promoters such as pTet. Due to its conjugated system the molecule 
exhibits some fluorescence [44]. MW = 462.88 g/mol. 1 μg/ml = 2.16 μM.
constitutive promoter – a promoter which is always activated, resulting in continuous 
transcription of the downstream DNA.
cross-talk – unwanted transfer of signals between communication channels. In this 
context; unwanted interference, due to lack of orthogonality, between a biocircuit 
and other systems such as the regulatory functions of a transformed host cell. 
GFP – Green fluorescent protein, a protein which fluoresces in the green light spectra. 
Different versions are available, such as deGFP (destabilized enhanced GFP) and 
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sfGFP (superfolder GFP) used in this project. In TX-TL experiments, sfGFP result 
in a much higher fluorescence than deGFP.
inducer – a molecule that activated gene expression, by either disabling a repressor or 
inducing an activator. 
in silico – term used to describe an experiment of process conducted or produced by 
means of computer modeling or computer simulation.
in vitro – term used to describe a process performed or taking place in a test tube, 
culture dish, or elsewhere outside a living organism.
in vivo – term used to describe a process taking place in a living organism.
Isopropyl-b-D-thiogalactopyranoside (IPTG) – a chemical mimic of lactose which acts as 
an inducer for LacI repressor. By binding to the LacI dimer the complex undergoes a
conformation change which makes it unable to bind to the Lac operon on promoters 
such as pLac and pTac [12].
orthogonality – in this context, orthogonality means that any given set of modules do 
not overlap in their regulatory functions or interfere with one another. E.g. the 
repressors TetR-pTet and LacI-pLac can be said to be orthogonal since TetR protein
cannot repress the pLac promoter, and vise versa, and because the two modules can 
function along side one another without any significant interactions disturbing the 
logic. 
positive control – in this context, positive control refers to a construct known to 
constitutively express GFP and can be used as a reference to determine if an 
experiment was prepared correctly.
reporter construct (reporter) – a construct which expresses a marker, such as GFP, 
which makes the output measurable by available methods. Reporters are used as a 
way of quantifying gene expression, and provides the researcher with a means to 
“see” what genes are expressing under certain conditions.
repressor – a protein or protein complex which stops the expression from a construct by 
hindering RNAP from binding to the promoter. Repressors used in this project are 
TetR and LacI.
restriction digest enzyme – Enzymes which have the property of cleaving DNA molecules
at or near specific sequences of bases. Enzymes used in this project are BsaI, BbsI 
and DpnI.
RFP – Red fluorescent protein. (see GFP)
RFU – Relative Fluorescence Units, the measuring unit given by a plate-reader when 
measuring fluorescence (e.g. from fluorescent reporters). Can be converted to nM 
units with sufficient calibration data.
transcription factor – a protein or protein complex which effects the expression of a gene.
Either a repressor or an activator.
type-III secretion systems (T3SS) – an invasion system used by pathogenic bacteria to 
50
secrete effector proteins into host the cells of host organisms [36]. These T3SS 
contain a large number of proteins which can be used in other contexts to build 
biocircuits [13].
7.2. Protocols and methods
7.2.1. Golden Braid reaction protocol
Golden Braid (GB) reactions were carried out in accordance with the following protocol.
For each reaction the following reactants were added to a 500 μl tube:
• 1 μl NEB BsaI-HF (restriction digest enzyme)
• 1 μl NEB T4 DNA Ligase
• 1.5 μl 10X T4 DNA Ligase Buffer
• 1.5 μl 10X BSA protein
50 ng of vector backbone, along with equimolar amount of the inserts (P,U,C and T) 
were added to the tube. Nuclease free water was added to a total volume of 30 μl. The 
mixture was spun down in a table-top spinner, flicked to mix and spun down again.  A 
'Bio-Rad C1000 Touch Thermal Cycler' was used to control the reaction temperature 
during digest and ligation.
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7.3. Additional results
7.3.1. Model of PipaH AND-gate
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Figure 23: Surface plot of the modeled pipaH AND-gate system clearly 
displays a peak expression around 2-4 nM of each of the two DNA constructs.
7.3.2. Full circuit TX-TL assembly
An attempt was made at assembling the ful circuit in TX-TL, as shown in Figure 22. 
7.3.3. Complete circuit model results
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Figure 24: Full circuit assembled in a TX-TL experiment. The result does not follow the 
predicted circuit logic.
Figure 25: Modeling result of varying repressor concentrations, shown as heat map (left) and 3D 
bars from a different angle (right).
7.3.4. pSicA AND-gate
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Figure 26: Data from pSicA AND-gate characterization rescaled to show the expression from the
OFF-states of the logic. Left: Es5 homogenizer extract. Right: eZS3 bead-deating extract
